company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,708000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4604000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4604000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3251000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3219000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7823000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7823000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7823000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7823000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16015000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16015000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,FY,2010-01-01,2010-12-31,2012-03-27 16:51:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,807000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,110000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,917000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-917000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2611000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1694000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1694000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1694000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1694000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20461000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20461000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21200000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 09:41:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2359000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,146000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2505000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2505000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-72000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-64000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2569000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2569000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2569000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2569000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,368294000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,368294000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,256900000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2010.0,Q2,2010-04-01,2010-06-30,2011-08-15 09:44:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1944000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1494000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3438000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3438000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,43000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8080000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8123000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4685000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4685000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4685000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4685000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23983000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24050000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,FY,2011-01-01,2011-12-31,2013-04-01 15:13:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,395000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,506000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,901000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-901000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4396000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4409000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3508000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3508000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3508000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3508000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23983000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24050000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,505000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,439000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,944000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-944000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2221000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2200000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3144000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3144000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3144000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3144000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18085000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18085000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3,2011-07-01,2011-09-30,2011-11-14 09:41:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1549000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,988000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2537000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2537000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3684000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3714000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18085000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18085000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,338000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,234000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,572000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-572000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,225000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,224000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-348000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-348000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-348000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-348000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34800000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2,2011-04-01,2011-06-30,2012-08-13 14:50:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1044000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,549000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1593000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1593000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5905000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5914000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4321000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4321000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4321000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4321000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34800000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,706000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,315000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1021000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1021000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5680000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5690000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4669000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4669000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4669000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4669000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20565000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25001000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20300000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2011.0,Q1,2011-01-01,2011-03-31,2012-05-14 21:48:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1545000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2075000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3620000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3620000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1568000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1543000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5163000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5163000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5163000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5163000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24600000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,FY,2012-01-01,2012-12-31,2014-03-31 16:07:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,562000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,562000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1124000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1124000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5397000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5388000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6512000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6512000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6512000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6512000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24600000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,273000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,357000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,630000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-630000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-139000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-134000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-764000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-764000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-764000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-764000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3,2012-07-01,2012-09-30,2012-11-14 15:48:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,983000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1513000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2496000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2496000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3829000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3845000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1349000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1349000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1349000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1349000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1378000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2019000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3397000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3397000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8225000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8254000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4857000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4857000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4857000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4857000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,390000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,860000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1250000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1250000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,645000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,648000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-602000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-602000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-602000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-602000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2,2012-04-01,2012-06-30,2012-08-13 14:50:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,710000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1156000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1866000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1866000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3968000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3979000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2113000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2113000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2113000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2113000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1610000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2101000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3711000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3711000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,45000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6143000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6188000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2477000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2477000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2477000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2477000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,320000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,296000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,616000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-616000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3323000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3331000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2715000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2715000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2715000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2715000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1,2012-01-01,2012-03-31,2012-05-14 21:48:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1558000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1475000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3033000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3033000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5723000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5764000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2731000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2731000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2731000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2731000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1334000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,597000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1931000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1931000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3774000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3776000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1845000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1845000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1845000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1845000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31714000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30800000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,FY,2013-01-01,2013-12-31,2014-03-31 16:07:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,327000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,89000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,416000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-416000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1525000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1528000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1112000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1112000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1112000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1112000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31714000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30800000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,275000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-224000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1715000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1715000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1766000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1766000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1766000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1766000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8386000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8386000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 17:09:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1007000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,508000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1515000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1515000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2249000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2248000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,733000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,733000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,733000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,733000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8386000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8386000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1569000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1070000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2639000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2639000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3148000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3140000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5779000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5779000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5779000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5779000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,8386000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,8386000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,373000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,554000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,927000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-927000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7537000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7534000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6607000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6607000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6607000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6607000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25639000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 08:26:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,732000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,732000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1464000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1464000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3964000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3963000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2499000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2499000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2499000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2499000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25639000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1567000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1651000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3218000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3218000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1572000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1559000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4777000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4777000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4777000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4777000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25639000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,359000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,178000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,537000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-537000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3573000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3571000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4108000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4108000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4108000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4108000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 15:16:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1584000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1957000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3541000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3541000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8464000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8445000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11986000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11986000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11986000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11986000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2520000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,357000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2877000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2877000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,699000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,701000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2176000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2176000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2176000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2176000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9871000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9871000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9900000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,FY,2014-01-01,2014-12-31,2015-03-31 17:18:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,626000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,165000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,791000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-791000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2178000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2179000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1388000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1388000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1388000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1388000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9871000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9871000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9900000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,531000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,88000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,619000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-619000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,999000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,999000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,380000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,380000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,380000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,380000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9861000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11154000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3,2014-07-01,2014-09-30,2014-11-13 17:09:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1894000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,192000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2086000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2086000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1479000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1478000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3564000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3564000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3564000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3564000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9861000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11154000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2221000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,281000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2502000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2502000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,46000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,50000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2452000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2452000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2452000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2452000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9861000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11154000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,858000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,72000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,930000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-930000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,180000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-750000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-750000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-750000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-750000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29538000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29538000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2,2014-04-01,2014-06-30,2014-08-11 08:26:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1363000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,104000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1467000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1467000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2478000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2477000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3944000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3944000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3944000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3944000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29538000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29538000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1965000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-31000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1934000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1934000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2668000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2664000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29538000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29538000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,505000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,537000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-537000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2655000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2657000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3194000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3194000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3194000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3194000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29308000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29308000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1,2014-01-01,2014-03-31,2014-05-15 15:16:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1480000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,451000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1931000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1931000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4692000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4690000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2759000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2759000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2759000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2759000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29308000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29308000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1634000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,256000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1890000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1890000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1228000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1231000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-659000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-659000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-659000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-659000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10827000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,FY,2015-01-01,2015-12-31,2017-03-29 16:36:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,480000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,71000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,551000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-551000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-540000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-540000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-540000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-540000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10827000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,250000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,88000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,338000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-338000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,214000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,215000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-123000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-123000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-123000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-123000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10929000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10929000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12300000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 15:53:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1154000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,185000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1339000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1339000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1218000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1220000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-119000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-119000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-119000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-119000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10929000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10929000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12300000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1780000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,350000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2130000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2130000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3396000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3399000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1269000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1269000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1269000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1269000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10929000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10929000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12300000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,495000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,549000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-549000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,375000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,376000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-173000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-173000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-173000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-173000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10830000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10830000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 12:50:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,904000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,97000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1001000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1001000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1004000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1005000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10830000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10830000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2061000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,350000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2411000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2411000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4181000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4183000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1772000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1772000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1772000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1772000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10830000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10830000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,409000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,452000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-452000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,629000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,629000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,177000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10605000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11870000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8900000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1,2015-01-01,2015-03-31,2016-05-12 16:50:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2424000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,368000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2792000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2792000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3983000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3987000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1195000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1195000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1195000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1195000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10605000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11870000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,8900000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2399000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,472000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2871000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2871000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,74000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,82000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2789000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2789000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2789000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2789000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12765000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,FY,2016-01-01,2016-12-31,2018-03-28 16:47:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,972000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,174000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1146000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1146000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1143000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1143000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1143000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1143000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12765000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,452000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,112000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,564000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-564000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,59000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,62000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-502000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-502000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-502000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-502000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12600000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3,2016-07-01,2016-09-30,2017-11-13 14:30:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1427000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,298000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1725000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1725000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,73000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,79000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1646000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1646000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1646000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1646000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12600000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1907000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,369000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2276000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2276000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,83000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,90000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2186000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2186000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2186000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2186000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12600000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,568000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,139000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,707000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-707000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-724000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-724000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-724000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-724000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12813000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12813000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2,2016-04-01,2016-06-30,2016-08-12 12:50:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,975000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,186000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1161000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1161000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,17000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1144000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1144000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1144000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1144000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12813000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12813000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1705000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,345000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2050000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2050000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,238000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,243000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1807000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1807000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1807000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1807000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12813000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12813000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,407000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,454000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-454000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,34000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-420000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-420000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-420000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-420000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1,2016-01-01,2016-03-31,2016-05-12 16:50:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1632000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,260000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1892000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1892000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,633000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,636000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1256000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1256000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1256000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1256000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5015000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1936000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6951000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6951000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,47000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-142000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-95000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7046000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7046000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7046000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7046000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15014000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,FY,2017-01-01,2017-12-31,2018-03-28 16:47:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1629000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,886000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2515000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2515000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,202000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,225000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2290000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2290000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2290000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2290000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15000000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15014000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1694000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,492000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2186000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2186000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-182000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-166000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2352000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2352000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2352000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2352000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15740000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15740000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3,2017-07-01,2017-09-30,2017-11-13 14:30:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3386000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1050000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4436000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4436000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-344000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-320000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4756000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4756000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4756000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4756000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15740000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15740000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4358000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1224000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5582000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5582000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-343000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-317000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5899000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5899000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5899000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5899000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15740000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15740000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1146000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,333000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1479000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1479000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-124000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-119000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1598000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14192000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14192000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2,2017-04-01,2017-06-30,2018-08-13 14:00:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1692000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,558000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2250000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2250000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-162000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-154000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2404000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2404000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2404000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2404000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14192000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14192000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3116000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,844000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3960000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3960000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-102000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-89000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4049000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4049000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4049000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4049000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14192000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14192000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,546000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,225000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,771000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-771000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-806000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-806000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-806000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-806000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1,2017-01-01,2017-03-31,2018-05-14 12:18:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2538000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,650000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3188000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3188000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3175000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3175000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3175000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3175000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13643000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5401000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5008000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10409000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10409000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,348000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,173000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,521000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9888000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9888000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9888000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9888000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 11:38:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1382000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1723000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3105000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3105000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,115000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,121000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2984000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2984000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2984000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2984000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18942000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1050000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1798000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2848000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2848000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,101000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,99000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2749000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2749000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2749000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2749000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19600000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18968000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18968000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3,2018-07-01,2018-09-30,2018-11-13 13:32:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4019000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3285000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7304000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7304000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,233000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,167000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6904000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6904000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6904000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6904000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19600000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18968000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18968000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5648000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4171000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9819000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9819000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,256000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,369000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,625000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9194000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9194000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9194000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9194000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19600000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18968000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18968000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1867000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,798000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2665000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2665000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,73000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,78000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2587000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2587000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2587000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2587000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18585000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18585000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2,2018-04-01,2018-06-30,2018-08-13 14:00:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2969000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1487000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4456000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4456000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,132000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,169000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,301000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4155000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4155000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4155000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4155000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18585000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18585000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6292000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2865000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9157000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9157000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,171000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,189000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,360000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8797000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8797000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8797000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8797000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18500000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18585000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18585000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1102000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,689000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1791000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1791000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,59000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,164000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,223000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1568000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1568000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1568000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1568000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18430000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18430000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1,2018-01-01,2018-03-31,2018-05-14 12:18:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5571000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7971000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7971000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,103000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,60000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,163000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7808000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7808000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7808000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7808000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17400000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18430000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18430000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2481000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1172000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3653000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3653000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-17000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-43000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,43000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3610000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3610000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3610000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3610000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7402000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5607000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13009000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13009000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,315000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,234000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12775000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12775000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12775000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12775000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 11:38:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1068000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,795000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1863000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1863000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,70000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,54000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1809000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1809000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1809000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1809000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 10:50:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4921000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4435000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9356000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9356000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,246000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,191000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9165000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9165000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9165000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9165000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6303000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6158000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12461000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12461000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,361000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-32000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,312000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12149000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12149000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12149000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12149000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2844000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1969000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4813000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4813000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,110000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,83000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4730000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4730000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4730000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4730000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 11:19:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3853000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3640000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7493000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7493000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,176000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,137000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7356000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7356000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7356000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7356000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6285000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7161000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13446000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13446000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,392000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,357000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13089000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13089000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13089000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13089000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19700000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1009000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1671000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2680000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2680000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,66000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,54000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2626000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2626000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2626000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2626000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-18800000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1,2019-01-01,2019-03-31,2020-05-14 11:11:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5308000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5990000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11298000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11298000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,355000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,352000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10946000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10946000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10946000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10946000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-18800000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8835000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5329000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14164000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14164000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,284000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-95000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,189000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13975000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13975000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13975000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13975000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-20100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2442000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1393000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3835000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3835000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3826000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3826000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3826000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3826000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-20100000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19896000.0
FENNEC PHARMACEUTICALS INC.,FENC,,0001211583,2020.0,Q1,2020-01-01,2020-03-31,2020-05-14 11:11:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
